Scientists generate a mouse embryo model that develops neural tubes
The new mouse embryo model system promises to spur research into developmental health and disease.
List view / Grid view
The new mouse embryo model system promises to spur research into developmental health and disease.
31 August 2022 | By Eurofins Discovery
Watch our on-demand webinar where our expert speaker will explore the possibilities for designing selective small molecules targeting the SH2 domains of STAT proteins plus more.
Application note: Quantifying T Cell response in 3D tumour spheroids using advanced flow cytometry workflows.
19 August 2022 | By Sartorius
Want to learn about the latest research and development of cell models in rare diseases? Then watch this virtual panel discussion to hear from industry experts.
This publications review overviews advanced flow cytometry applications in infectious disease and immuno-oncology.
Learn about current and emerging immune checkpoint molecules that are being investigated as potential immuno-oncology targets.
This guide highlights the four major stages of TPD, the challenges at each step and questions you should ask yourself.
Learn about DLS, a powerful method to characterise the purity and aggregation state of your biologics for improved candidate selection.
R&D Systems offers custom antibody production services to engineer the right antibody to solve your research question with confidence.
In rodent models of ALS, the introduced neuroprotective protein slowed disease progression and increased life span.
In a new study, researchers have found that light can be used to naturally balance a cell’s mitochondria.
A T-cell bispecific antibody shows potent anti-tumour activity in preclinical models of epidermal growth factor receptor variant III (EGFRvIII) mutant glioblastoma.
Researchers have developed a nanobody that can penetrate the tough exterior of brain cells and untangle misshapen proteins that lead to Parkinson’s disease.
This whitepaper overviews how high throughput, multi-parametric analysis accelerates antibody discovery workflows.
Scientists are developing an effective stem cell-based therapy to regenerate photoreceptors cells and restore sight in people with blindness.